Chronic allograft nephropathy or interstitial fibrosis and tubular atrophy: What is in a name?

Current Opinion in Nephrology and Hypertension

Volumn 23, Issue 3, 2014, Pages 245-250

  Haas, Mark ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

chronic rejection; interstitial inflammation; kidney injury; renal transplantation

Indexed keywords

MOLECULAR MARKER; BIOLOGICAL MARKER;

ACUTE KIDNEY FAILURE; ATROPHY; CHRONIC ALLOGRAFT NEPHROPATHY; DISEASE ASSOCIATION; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT; KIDNEY FIBROSIS; LONG TERM SURVIVAL; NEPHRITIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUBULAR ATROPHY; BIOPSY; CHRONIC DISEASE; CLASSIFICATION; FIBROSIS; GRAFT REJECTION; KIDNEY TRANSPLANTATION; KIDNEY TUBULE; METABOLISM; NEPHRITIS, INTERSTITIAL; NOMENCLATURE; PATHOLOGY; PREDICTIVE VALUE; RISK FACTOR; TIME; TREATMENT OUTCOME;

ATROPHY; BIOLOGICAL MARKERS; BIOPSY; CHRONIC DISEASE; FIBROSIS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; NEPHRITIS, INTERSTITIAL; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TERMINOLOGY AS TOPIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 84898546276     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/01.mnh.0000444811.26884.2d     Document Type: Review

References (31)

1. Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States. N Engl J Med 2000; 342:605-612.
2. Pascual M, Theruvath T, Kawai T, et al. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002; 346:580-590.
3. Sellares J, de Freitas DG, Mengel M, et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 2012; 12:388-399.
4. Lamb KE, Lodhi S, Meier-Kriesche H-U. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant 2011; 11:450-462.
5. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 1993; 44:411-422.
6. Solez K, Colvin RB, Racusen LC, et al. Banff 05 meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (CAN). Am J Transplant 2007; 7:518-526.
7. Gourishankar S, Leduc R, Connett J, et al. Pathological and clinical characterization of the troubled transplant: data from the DeKAF study. Am J Transplant 2010; 10:324-330.
8. Gloor JM, Sethi S, Stegall MD, et al. Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant 2007; 7:2124-2132.
9. Sis B, Campbell PM, Muller T, et al. Transplant glomerulopathy, late antibodymediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007; 7:1743-1752.
10. Mauiyyedi S, Pelle PD, Saidman S, et al. Chronic humoral rejection: identification of antibody-mediated chronic allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001; 12:574-582.
11. Hill GS, Nochy D, Bruneval P, et al. Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation. J Am Soc Nephrol 2011; 22:975-983.
12. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55:713-723.
13. Mengel M, Reeve J, Bunnag S, et al. Scoring total inflammation is superior to the current Banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts.AmJ Transplant2009; 9:1859-1867.
14. Mannon RB, Matas AJ, Grande J, et al. Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant 2010; 10:2066-2073.
15. Famulski KS, Reeve J, de Freitas DG, et al. Kidney transplants with progressing chronic disease express high levels of acute kidney injury transcripts. Am J Transplant 2013; 13:634-644.
16. Nizze H, Mihatsch MJ, Zollinger HU, et al. Cyclosporine-associated nephropathy in patients with heart and bone marrow transplants. Clin Nephrol 1988; 30:248-260.
17. Myers BD, Newton L. Cyclosporine-induced chronic nephropathy: an obliterative microvascular renal injury. J Am Soc Nephrol 1991; 2:S45-S52.
18. Young BA, Burdmann EA, Johnson RJ, et al. Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int 1985; 48:439-448.
19. Pichler RH, Franceschini N, Young BA, et al. Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. J Am Soc Nephrol 1995; 6:1186-1196.
20. Viera JM Jr, Noronha IL, Malheiros DM, et al. Cyclosporine-induced interstitial fibrosis and arteriolar TGF-beta expression with preserved renal blood flow. Transplantation 1999; 68:1746-1753.
21. Zhong Z, Arteel GE, Connor HD, et al. Cyclosporine A increases hypoxia and free radical production in rat kidneys: prevention by dietary glycine. Am J Physiol 1998; 275:F595-F604.
22. Jennings P, Koppelstaetter C, Aydin S, et al. Cyclosporine A induces senescence in renal tubular epithelial cells. Am J Physiol 2007; 293:F831-F838.
23. Naesens M, Kuypers DRJ, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009; 4:481-508.
24. Nankivell BJ, Burrows RJ, Fung CL-S, et al. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349:2326-2333.
25. Snanoudj R, Royal V, Elie C, et al. Specificity of histological markers of longterm CNI nephrotoxicity in kidney-transplant recipients under low-dose cyclosporine therapy. Am J Transplant 2011; 11:2635-2646.
26. Abrass CK, Berfield AK, Stehman-Breen C, et al. Unique changes in interstitial extracellular matrix composition are associated with rejection and cyclosporine toxicity in human renal allograft biopsies. Am J Kidney Dis 1999; 33:11-20.
27. Koop K, Bakker RC, Eikmans M, et al. Differentiation between chronic rejection and chronic cyclosporine toxicity by analysis of renal cortical mRNA. Kidney Int 2004; 66:2038-2046.
28. Anglicheau D, Muthukumar T, Hummel A, et al. Discovery and validation of a molecular signature for the noninvasive diagnosis of human renal allograft fibrosis. Transplantation 2012; 93:1136-1146.
29. Rodder S, Scherer A, Raulf F, et al. Renal allografts with IF/TA display distinct expression profiles of metzincins and related genes. Am J Transplant 2009; 9:517-526.
30. Scian MJ, Maluf DJ, David KG, et al. MicroRNA profiles in allograft tissues and paired urines associated with chronic allograft dysfunction with IF/TA. Am J Transplant 2011; 11:2110-2122.
31. Ben-Dov IZ, Muthukumar T, Morozov P, et al. MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis. Transplantation 2012; 94:1086-1094.